Ticker ARQT – Arcutis – sales, description, marketcap – Tickerday.com

ARQT

Arcutis

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 999.03M; Volume: 274.26K; AvgVol 3m: 127.84K; Beta: –;

Cost estimate:

P/E: –; EPS: -2.84; EPS growth quarter/prev quarter: -130.90%;

EPS growth this year: -118.10%; EPS growth past 5 years: ;

EPS ttm: -2.84;

P/S: ; P/B: 4.27; P/Cashflow: 4.80; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -58.20%; ROE – return on equity: -108.70%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.90%; Insider Transactions:236.86%;

Institutional Ownership: 88.60%; Institutional Transactions: 2.85%;

Data update: 07/10/2020.